Glenmark Pharmaceuticals
GLENMARK.NS
#2587
Rank
S$7.41 B
Marketcap
$26.27
Share price
0.21%
Change (1 day)
106.65%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Total assets

Total assets on the balance sheet as of March 2024 : S$2.28 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's total assets are S$2.28 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Glenmark Pharmaceuticals - Total assets on balance sheet (from 2012 to 2024)

Total assets by year

Year Total assets Change
2023-03-31S$3.13 B2.83%
2022-03-31S$3.04 B6.47%
2021-03-31S$2.86 B3.21%
2020-03-31S$2.77 B6.86%
2019-03-31S$2.59 B-0.97%
2018-03-31S$2.62 B-0.5%
2017-03-31S$2.63 B19.38%
2016-03-31S$2.20 B3.46%
2015-03-31S$2.13 B17.35%
2014-03-31S$1.81 B10.87%
2013-03-31S$1.63 B12.7%
2012-03-31S$1.45 B0.91%
2011-03-31S$1.44 B-5.53%
2010-03-31S$1.52 B19.58%
2009-03-31S$1.27 B25.34%
2008-03-31S$1.01 B48.98%
2007-03-31S$0.68 B39.32%
2006-03-31S$0.49 B41.26%
2005-03-31S$0.34 B97.12%
2004-03-31S$0.17 B